Xcovery Holdings, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions

Phase 1
Completed
Conditions
Bioequivalency
Interventions
Drug: Ensartinib Hydrochloride
First Posted Date
2022-12-27
Last Posted Date
2024-02-20
Lead Sponsor
Xcovery Holdings, Inc.
Target Recruit Count
32
Registration Number
NCT05665283
Locations
🇺🇸

ICON - Early Development Services, Lenexa, Kansas, United States

BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1
Not yet recruiting
Conditions
Non-small Cell Lung Carcinoma
Interventions
Drug: BPI-361175
First Posted Date
2022-05-26
Last Posted Date
2022-10-20
Lead Sponsor
Xcovery Holdings, Inc.
Target Recruit Count
30
Registration Number
NCT05393466

Expanded Access to Ensartinib for Participants With ALK+ NSCLC

First Posted Date
2019-10-31
Last Posted Date
2022-10-20
Lead Sponsor
Xcovery Holdings, Inc.
Registration Number
NCT04146571
Locations
🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

🇺🇸

Stanford University, Stanford, California, United States

🇺🇸

Walter Reed National Military Medical Center, Bethesda, Maryland, United States

and more 1 locations

eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Phase 3
Active, not recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
Drug: X-396 (ensartinib)
Drug: crizotinib
First Posted Date
2016-05-10
Last Posted Date
2024-08-20
Lead Sponsor
Xcovery Holdings, Inc.
Target Recruit Count
290
Registration Number
NCT02767804
Locations
🇪🇸

Hospital Vall d'Hebrón, Barcelona, Spain

🇪🇸

Hospital Son Ltatzer, Palma de Mallorca, Spain

🇦🇷

Sanatorio Parque S.A., Rosario, Argentina

and more 66 locations

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

First Posted Date
2012-06-21
Last Posted Date
2021-10-06
Lead Sponsor
Xcovery Holdings, Inc.
Target Recruit Count
131
Registration Number
NCT01625234
Locations
🇺🇸

City of Hope National Med Ctr, Duarte, California, United States

🇺🇸

Stanford University, Stanford, California, United States

🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

and more 11 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy